메뉴 건너뛰기




Volumn 54, Issue 11, 2016, Pages 2636-2642

Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis

Author keywords

Egger s regression test; trims and fill analysis; type 2 diabetic mellitus

Indexed keywords

BIGUANIDE DERIVATIVE; METFORMIN; ANTIDIABETIC AGENT;

EID: 84966694930     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880209.2016.1176057     Document Type: Article
Times cited : (35)

References (28)
  • 1
    • 77952116629 scopus 로고    scopus 로고
    • Metformin in cancer therapy: a new perspective for an old antidiabetic drug?
    • I.Ben Sahra, Y.Le Marchand-Brustel, J.F.Tanti, F.Bost 2010. Metformin in cancer therapy:a new perspective for an old antidiabetic drug? Mol Cancer Ther. 9:1092–1099.
    • (2010) Mol Cancer Ther , vol.9 , pp. 1092-1099
    • Ben Sahra, I.1    Le Marchand-Brustel, Y.2    Tanti, J.F.3    Bost, F.4
  • 2
    • 84857073798 scopus 로고    scopus 로고
    • Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis
    • M.Bodmer, C.Becker, C.Meier, S.S.Jick, C.R.Meier 2012. Use of metformin is not associated with a decreased risk of colorectal cancer:a case-control analysis. Cancer Epidemiol Biomarkers Prev. 21:280–286.
    • (2012) Cancer Epidemiol Biomarkers Prev , vol.21 , pp. 280-286
    • Bodmer, M.1    Becker, C.2    Meier, C.3    Jick, S.S.4    Meier, C.R.5
  • 3
    • 84991494403 scopus 로고    scopus 로고
    • Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study
    • M.Cardel, S.M.Jensen, A.Pottegard, T.L.Jorgensen, J.Hallas 2014. Long-term use of metformin and colorectal cancer risk in type II diabetics:a population-based case-control study. Cancer Med. 3:1458–1466.
    • (2014) Cancer Med , vol.3 , pp. 1458-1466
    • Cardel, M.1    Jensen, S.M.2    Pottegard, A.3    Jorgensen, T.L.4    Hallas, J.5
  • 4
    • 43049089327 scopus 로고    scopus 로고
    • Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea
    • Y.W.Chung, D.S.Han, K.H.Park, C.S.Eun, K.S.Yoo, C.K.Park 2008. Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus:a case-control study in Korea. Dis Colon Rectum. 51:593–597.
    • (2008) Dis Colon Rectum , vol.51 , pp. 593-597
    • Chung, Y.W.1    Han, D.S.2    Park, K.H.3    Eun, C.S.4    Yoo, K.S.5    Park, C.K.6
  • 5
    • 68449094325 scopus 로고    scopus 로고
    • The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    • C.J.Currie, C.D.Poole, E.A.Gale 2009. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 52:1766–1777.
    • (2009) Diabetologia , vol.52 , pp. 1766-1777
    • Currie, C.J.1    Poole, C.D.2    Gale, E.A.3
  • 8
    • 40349105880 scopus 로고    scopus 로고
    • Metabolic syndrome, hyperinsulinemia, and colon cancer: a review
    • E.Giovannucci 2007. Metabolic syndrome, hyperinsulinemia, and colon cancer:a review. Am J Clin Nutr. 86:s836–s842.
    • (2007) Am J Clin Nutr , vol.86 , pp. s836-s842
    • Giovannucci, E.1
  • 9
    • 33847072201 scopus 로고    scopus 로고
    • AMP-activated protein kinase as a drug target
    • D.G.Hardie 2007. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol. 47:185–210.
    • (2007) Annu Rev Pharmacol Toxicol , vol.47 , pp. 185-210
    • Hardie, D.G.1
  • 10
    • 84863683395 scopus 로고    scopus 로고
    • The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese
    • M.C.Hsieh, T.C.Lee, S.M.Cheng, S.T.Tu, M.H.Yen, C.H.Tseng 2012. The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese. Exp Diabetes Res. 2012:413782.
    • (2012) Exp Diabetes Res , vol.2012 , pp. 413782
    • Hsieh, M.C.1    Lee, T.C.2    Cheng, S.M.3    Tu, S.T.4    Yen, M.H.5    Tseng, C.H.6
  • 11
    • 40349112853 scopus 로고    scopus 로고
    • Metabolic syndrome, hyperinsulinemia, and cancer
    • I.R.Hsu, S.P.Kim, M.Kabir, R.N.Bergman 2007. Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr. 86:s867–s871.
    • (2007) Am J Clin Nutr , vol.86 , pp. s867-s871
    • Hsu, I.R.1    Kim, S.P.2    Kabir, M.3    Bergman, R.N.4
  • 12
    • 0345167800 scopus 로고    scopus 로고
    • TSC2 mediates cellular energy response to control cell growth and survival
    • K.Inoki, T.Zhu, K.L.Guan 2003. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 115:577–590.
    • (2003) Cell , vol.115 , pp. 577-590
    • Inoki, K.1    Zhu, T.2    Guan, K.L.3
  • 13
    • 0031695628 scopus 로고    scopus 로고
    • Diet, lifestyle, and colorectal cancer: is hyperinsulinemia the missing link?
    • Y.I.Kim 1998. Diet, lifestyle, and colorectal cancer:is hyperinsulinemia the missing link? Nutr Rev. 56:275–279.
    • (1998) Nutr Rev , vol.56 , pp. 275-279
    • Kim, Y.I.1
  • 14
    • 27944450832 scopus 로고    scopus 로고
    • Diabetes mellitus and risk of colorectal cancer: a meta-analysis
    • S.C.Larsson, N.Orsini, A.Wolk 2005. Diabetes mellitus and risk of colorectal cancer:a meta-analysis. J Natl Cancer Inst. 97:1679–1687.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 1679-1687
    • Larsson, S.C.1    Orsini, N.2    Wolk, A.3
  • 15
    • 78651451726 scopus 로고    scopus 로고
    • Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
    • M.S.Lee, C.C.Hsu, M.L.Wahlqvist, H.N.Tsai, Y.H.Chang, Y.C.Huang 2011. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese:a representative population prospective cohort study of 800,000 individuals. BMC Cancer. 11:20.
    • (2011) BMC Cancer , vol.11 , pp. 20
    • Lee, M.S.1    Hsu, C.C.2    Wahlqvist, M.L.3    Tsai, H.N.4    Chang, Y.H.5    Huang, Y.C.6
  • 16
    • 69549097703 scopus 로고    scopus 로고
    • New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes
    • G.Libby, L.A.Donnelly, P.T.Donnan, D.R.Alessi, A.D.Morris, J.M.Evans 2009. New users of metformin are at low risk of incident cancer:a cohort study among people with type 2 diabetes. Diabetes Care. 32:1620–1625.
    • (2009) Diabetes Care , vol.32 , pp. 1620-1625
    • Libby, G.1    Donnelly, L.A.2    Donnan, P.T.3    Alessi, D.R.4    Morris, A.D.5    Evans, J.M.6
  • 17
    • 84858695046 scopus 로고    scopus 로고
    • Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis
    • H.Noto, A.Goto, T.Tsujimoto, M.Noda 2012. Cancer risk in diabetic patients treated with metformin:a systematic review and meta-analysis. PLoS One. 7:e33411.
    • (2012) PLoS One , vol.7 , pp. e33411
    • Noto, H.1    Goto, A.2    Tsujimoto, T.3    Noda, M.4
  • 22
    • 33847080728 scopus 로고    scopus 로고
    • AMP-activated protein kinase in metabolic control and insulin signaling
    • M.C.Towler, D.G.Hardie 2007. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res. 100:328–341.
    • (2007) Circ Res , vol.100 , pp. 328-341
    • Towler, M.C.1    Hardie, D.G.2
  • 24
    • 84990962502 scopus 로고    scopus 로고
    • G.Wells, B.Shea, D.O’Connell, J.Peterson, V.Welch, M.Losos, P.Tugwell (2011). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; [cited 2014]. Available from:http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
    • (2011)
    • Wells, G.1    Shea, B.2    O’Connell, D.3    Peterson, J.4    Welch, V.5    Losos, M.6    Tugwell, P.7
  • 25
    • 84928658794 scopus 로고    scopus 로고
    • Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality
    • H.Xu, M.C.Aldrich, Q.Chen, H.Liu, N.B.Peterson, Q.Dai, M.Levy, A.Shah, X.Han, X.Ruan,. 2014. Validating drug repurposing signals using electronic health records:a case study of metformin associated with reduced cancer mortality. J Am Med Inform Assoc. 22:179–191.
    • (2014) J Am Med Inform Assoc , vol.22 , pp. 179-191
    • Xu, H.1    Aldrich, M.C.2    Chen, Q.3    Liu, H.4    Peterson, N.B.5    Dai, Q.6    Levy, M.7    Shah, A.8    Han, X.9    Ruan, X.10
  • 26
    • 5144234027 scopus 로고    scopus 로고
    • Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
    • Y.X.Yang, S.Hennessy, J.D.Lewis 2004. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology. 127:1044–1050.
    • (2004) Gastroenterology , vol.127 , pp. 1044-1050
    • Yang, Y.X.1    Hennessy, S.2    Lewis, J.D.3
  • 27
    • 84858693012 scopus 로고    scopus 로고
    • Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis
    • Z.J.Zhang, Z.J.Zheng, H.Kan, Y.Song, W.Cui, G.Zhao, K.E.Kip 2011. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes:a meta-analysis. Diabetes Care. 34:2323–2328.
    • (2011) Diabetes Care , vol.34 , pp. 2323-2328
    • Zhang, Z.J.1    Zheng, Z.J.2    Kan, H.3    Song, Y.4    Cui, W.5    Zhao, G.6    Kip, K.E.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.